Over and above its pain-relieving effects, conolidine has shown a favorable safety margin in preclinical toxicology assessments. In contrast to opioids, which regularly cause respiratory depression at greater doses, conolidine has not developed indications of sizeable respiratory suppression. Additionally, behavioral assessments in murine models suggest an absence of drug-trying https://fredk591xww4.develop-blog.com/profile